19 May 2013
Keywords: amarillo, files, patent, treat, obesity, interferon, texas
Article | 16 June 2008
Texas, USA-based Amarillo Biosciences, a specialty firm focused on low-dose, orally-administered interferon as a treatment for a variety of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 June 2008
17 May 2013
© 2013 thepharmaletter.com